To view this email as a web page, click here.
September 10, 2018
 
What to know about this rare inherited retinal disease
In 1997, a book published by neurologist Oliver Sacks, MD, revealed an unusual trait in the inhabitants of the small Micronesian island of Pingelap.
Continue
ADVERTISEMENT
 
How retinal surgeons are practicing in 2018
From first-line anti-VEGF choice for AMD to learning a new surgical technique via video, the results from a 2018 global trends in retina survey are out.
Find out
ADVERTISEMENT
 
Brolucizumab: Next-generation of anti-VEGF therapy?
Learn how two large, phase III studies—HAWK and HARRIER—are the first that "individualize" treatment, says Pravin U. Dugel, MD.
Read more
ADVERTISEMENT
 
RELATED ARTICLES
 
Risuteganib for the treatment of DME
Fellows report increasing surgical experience during training
What APL-2 means for geographic atrophy
Two drugs better than one in DME therapy?
 
ADVERTISEMENT
How about a complimentary dinner program, plus invigorating discussion with experts and peers about Wet AMD and DME? Chicago, Saturday, October 27, 2018 brought to you by Ophthalmology Times and Regeneron. Save your seat now. »
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.